Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 439

1.

Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.

Ginsburg GS, Kuderer NM.

J Clin Oncol. 2012 Dec 1;30(34):4233-42. doi: 10.1200/JCO.2012.42.6114. Epub 2012 Oct 15. Review.

2.

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.

Goddard KA, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully SD, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL.

Genet Med. 2012 Jul;14(7):633-42. Review.

3.

Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.

Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn WF, Fenstermacher DA, Ginsburg GS, Goddard KA, Knaus WA, Lyman GH, Ramsey SD, Xu J, Freedman AN.

J Natl Cancer Inst. 2013 Jul 3;105(13):929-36. doi: 10.1093/jnci/djt108. Epub 2013 May 9.

4.

How comparative effectiveness research can help advance 'personalized medicine' in cancer treatment.

Ramsey SD, Veenstra D, Tunis SR, Garrison L, Crowley JJ, Baker LH.

Health Aff (Millwood). 2011 Dec;30(12):2259-68. doi: 10.1377/hlthaff.2010.0637.

5.

Comparative effectiveness research and personalized medicine: catalyzing or colliding?

Epstein RS, Teagarden JR.

Pharmacoeconomics. 2010;28(10):905-13. doi: 10.2165/11535830-000000000-00000.

PMID:
20831298
6.

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Roukos DH.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69. Review.

PMID:
20014921
7.

Genomic and personalized medicine: foundations and applications.

Ginsburg GS, Willard HF.

Transl Res. 2009 Dec;154(6):277-87. doi: 10.1016/j.trsl.2009.09.005. Epub 2009 Oct 1. Review.

PMID:
19931193
8.

Personalized medicine policy challenges: measuring clinical utility at point of care.

van Rooij T, Wilson DM, Marsh S.

Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):289-95. doi: 10.1586/erp.12.15. Review.

PMID:
22812553
9.

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.

McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D.

Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.

10.

Methods in comparative effectiveness research.

Armstrong K.

J Clin Oncol. 2012 Dec 1;30(34):4208-14. doi: 10.1200/JCO.2012.42.2659. Epub 2012 Oct 15. Review.

11.

Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.

Browman GP.

J Clin Oncol. 2012 Dec 1;30(34):4188-91. doi: 10.1200/JCO.2012.44.8225. Epub 2012 Oct 15. No abstract available.

PMID:
23071250
12.

Recent controversies on comparative effectiveness research investigations: Challenges, opportunities, and pitfalls.

Kirpalani H, Truog WE, D'Angio CT, Cotten M.

Semin Perinatol. 2016 Oct;40(6):341-347. doi: 10.1053/j.semperi.2016.05.004. Epub 2016 Aug 8.

13.

Building a personalized medicine infrastructure at a major cancer center.

Meric-Bernstam F, Farhangfar C, Mendelsohn J, Mills GB.

J Clin Oncol. 2013 May 20;31(15):1849-57. doi: 10.1200/JCO.2012.45.3043. Epub 2013 Apr 15. Review.

14.

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K.

CA Cancer J Clin. 2011 Sep-Oct;61(5):327-59. doi: 10.3322/caac.20128. Epub 2011 Aug 19. Review.

15.

Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research.

Lai TL, Liao OY, Kim DW.

Contemp Clin Trials. 2013 Nov;36(2):651-63. doi: 10.1016/j.cct.2013.08.007. Epub 2013 Aug 29.

PMID:
23994669
16.

Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.

Oderda GM, Balfe LM.

J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S19-24.

17.

Essential elements of personalized medicine.

Burke W, Brown Trinidad S, Press NA.

Urol Oncol. 2014 Feb;32(2):193-7. doi: 10.1016/j.urolonc.2013.09.002. Epub 2013 Dec 8.

18.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
19.

Improving health care outcomes through personalized comparisons of treatment effectiveness based on electronic health records.

Hoffman S, Podgurski A.

J Law Med Ethics. 2011 Fall;39(3):425-36. doi: 10.1111/j.1748-720X.2011.00612.x.

PMID:
21871040
20.

AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.

Maggi E, Montagna C.

Mutat Res. 2015 Dec;782:44-51. doi: 10.1016/j.mrfmmm.2015.10.005. Epub 2015 Nov 3.

PMID:
26554403

Supplemental Content

Support Center